# Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON)

> **NCT01539239** · NA · COMPLETED · sponsor: **Ivantis, Inc.** · enrollment: 1143 (actual)

## Conditions studied

- Primary Open Angle Glaucoma

## Interventions

- **DEVICE:** Hydrus Aqueous Implant
- **PROCEDURE:** Cataract surgery

## Key facts

- **NCT ID:** NCT01539239
- **Lead sponsor:** Ivantis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2017-06
- **Final completion:** 2020-06
- **Target enrollment:** 1143 (ACTUAL)
- **Last updated:** 2021-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01539239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01539239, "Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01539239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*